| hnRNP K is a haploinsufficient tumor suppressor that regulates proliferation and differentiation programs in hematologic malignancies M Gallardo, HJ Lee, X Zhang, C Bueso-Ramos, LR Pageon, M McArthur, ... Cancer cell 28 (4), 486-499, 2015 | 145 | 2015 |
| Aberrant hnRNP K expression: all roads lead to cancer M Gallardo, MJ Hornbaker, X Zhang, P Hu, C Bueso-Ramos, SM Post Cell Cycle 15 (12), 1552-1557, 2016 | 99 | 2016 |
| High resolution melting analysis for JAK2 Exon 14 and Exon 12 mutations: a diagnostic tool for myeloproliferative neoplasms I Rapado, S Grande, E Albizua, R Ayala, JA Hernández, M Gallardo, ... The Journal of Molecular Diagnostics 11 (2), 155-161, 2009 | 74 | 2009 |
| GMP-compliant manufacturing of NKG2D CAR memory T cells using CliniMACS prodigy L Fernández, A Fernández, I Mirones, A Escudero, L Cardoso, M Vela, ... Frontiers in Immunology 10, 2361, 2019 | 56 | 2019 |
| Validity test study of JAK2 V617F and allele burden quantification in the diagnosis of myeloproliferative diseases I Rapado, E Albizua, R Ayala, JA Hernández, L Garcia-Alonso, S Grande, ... Annals of hematology 87, 741-749, 2008 | 56 | 2008 |
| Novel deep targeted sequencing method for minimal residual disease monitoring in acute myeloid leukemia E Onecha, M Linares, I Rapado, Y Ruiz-Heredia, P Martinez-Sanchez, ... Haematologica, haematol. 2018.194712, 2018 | 42 | 2018 |
| Inhibition of related JAK/STAT pathways with molecular targeted drugs shows strong synergy with ruxolitinib in chronic myeloproliferative neoplasm S Barrio, M Gallardo, A Arenas, R Ayala, I Rapado, D Rueda, ... British journal of haematology 161 (5), 667-676, 2013 | 35 | 2013 |
| Epigenomic profiling in polycythaemia vera and essential thrombocythaemia shows low levels of aberrant DNA methylation S Barrio, M Gallardo, E Albizua, A Jimenez, I Rapado, R Ayala, F Gilsanz, ... Journal of clinical pathology 64 (11), 1010-1013, 2011 | 34 | 2011 |
| A potent isoprenylcysteine carboxylmethyltransferase (ICMT) inhibitor improves survival in Ras-driven acute myeloid leukemia NI Marín-Ramos, M Balabasquer, FJ Ortega-Nogales, IR Torrecillas, ... Journal of Medicinal Chemistry 62 (13), 6035-6046, 2019 | 33 | 2019 |
| MEK inhibition enhances the response to tyrosine kinase inhibitors in acute myeloid leukemia ML Morales, A Arenas, A Ortiz-Ruiz, A Leivas, I Rapado, ... Scientific Reports 9 (1), 18630, 2019 | 32 | 2019 |
| DNA-loaded extracellular vesicles in liquid biopsy: tiny players with big potential? S García-Silva, M Gallardo, H Peinado Frontiers in Cell and Developmental Biology 8, 622579, 2021 | 27 | 2021 |
| Uncovering the role of RNA-binding protein hnRNP K in B-cell lymphomas M Gallardo, P Malaney, MJL Aitken, X Zhang, TM Link, V Shah, ... JNCI: Journal of the National Cancer Institute 112 (1), 95-106, 2020 | 26 | 2020 |
| Monitoring of clonal evolution of acute myeloid leukemia identifies the leukemia subtype, clinical outcome and potential new drug targets for post-remission strategies or relapse E Onecha, I Rapado, ML Morales, G Carreño-Tarragona, ... Haematologica 106 (9), 2325, 2021 | 25 | 2021 |
| Proteomic analysis reveals heat shock protein 70 has a key role in polycythemia Vera M Gallardo, S Barrio, M Fernandez, A Paradela, A Arenas, O Toldos, ... Molecular Cancer 12, 1-12, 2013 | 25 | 2013 |
| Anexelekto/MER tyrosine kinase inhibitor ONO-7475 arrests growth and kills FMS-like tyrosine kinase 3-internal tandem duplication mutant acute myeloid leukemia cells by diverse … PP Ruvolo, H Ma, VR Ruvolo, X Zhang, H Mu, W Schober, I Hernandez, ... haematologica 102 (12), 2048, 2017 | 19 | 2017 |
| p53-independent ibrutinib responses in an Eμ-TCL1 mouse model demonstrates efficacy in high-risk CLL HJ Lee, M Gallardo, H Ma, X Zhang, CA Larsson, A Mejia, MJ Hornbaker, ... Blood cancer journal 6 (6), e434-e434, 2016 | 15 | 2016 |
| Real-life disease monitoring in follicular lymphoma patients using liquid biopsy ultra-deep sequencing and PET/CT A Jiménez-Ubieto, M Poza, A Martin-Muñoz, Y Ruiz-Heredia, S Dorado, ... Leukemia 37 (3), 659-669, 2023 | 12 | 2023 |
| Differential expression of JAK2 and Src kinase genes in response to hydroxyurea treatment in polycythemia vera and essential thrombocythemia E Albizua, M Gallardo, S Barrio, I Rapado, A Jimenez, R Ayala, D Rueda, ... Annals of hematology 90, 939-946, 2011 | 12 | 2011 |
| Myc-related mitochondrial activity as a novel target for multiple myeloma A Ortiz-Ruiz, Y Ruiz-Heredia, ML Morales, P Aguilar-Garrido, ... Cancers 13 (7), 1662, 2021 | 11 | 2021 |
| Hierarchy of mono- and biallelic TP53 alterations in multiple myeloma cell fitness U Munawar, L Rasche, N Müller, C Vogt, M Da-Via, L Haertle, ... Blood, The Journal of the American Society of Hematology 134 (10), 836-840, 2019 | 9 | 2019 |
joaquin martinez lopezComplutense UniversityVerified email at ucm.es
